Regarding 'moderate to severe hyperphosphataemia as an independent prognostic factor for 28-day mortality in adult patients with sepsis'

Junteng Zhou¹, Qi Zhang², Xiaojing Liu^{3

4}

Affiliations

¹ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Endocrinology and Metabolism, Sichuan University West China Hospital, Chengdu, China.
³ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China liuxq@scu.edu.cn.
⁴ Laboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.

Comment

Junteng Zhou et al. Emerg Med J. 2021 Feb.

. 2021 Feb;38(2):166.

doi: 10.1136/emermed-2020-210598. Epub 2020 Dec 21.

Junteng Zhou¹, Qi Zhang², Xiaojing Liu^{3

4}

¹ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Endocrinology and Metabolism, Sichuan University West China Hospital, Chengdu, China.
³ Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China liuxq@scu.edu.cn.
⁴ Laboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.

No abstract available

Keywords: clinical assessment; emergency department.

Conflict of interest statement

Competing interests: None declared.

Moderate to severe hyperphosphataemia as an independent prognostic factor for 28-day mortality in adult patients with sepsis.
Jang DH, Jo YH, Lee JH, Kim J, Park SM, Hwang JE, Lee DK, Park I, Lee CU, Lee SM. Jang DH, et al. Emerg Med J. 2020 Jun;37(6):355-361. doi: 10.1136/emermed-2019-208976. Epub 2020 Apr 22. Emerg Med J. 2020. PMID: 32321706